Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
DiaMedica Therapeutics Inc.DiaMedica Therapeutics Reports $7.7 Million Net Loss in Q2 2025
WILLAMETTE VALLEY VINEYARDS INCWillamette Valley Vineyards Reports Decline in Revenue and Profitability for Q2 and First Half of 2025
INTELLIGENT PROTECTION MANAGEMENT CORP.Intelligent Protection Management Corp. Reports 2,008.5% Revenue Growth to $5.7 Million in Q2 2025
PSQ Holdings, Inc.PSQ Holdings Reports 18% Revenue Growth in Q2 2025 Despite Net Loss
Fold Holdings, Inc.Fold Holdings Reports 59% Revenue Growth to $8.2 Million in Q2 2025
VOC Energy TrustVOC Energy Trust Reports Decline in Revenue and Profitability for Q2 and First Half of 2025
Rekor Systems, Inc.Rekor Systems Reports Revenue Decline and Improved Net Loss in Q2 2025
Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics Reports 96% Revenue Increase in Q2 2025 Amid Rising Losses
Stoke Therapeutics, Inc.Stoke Therapeutics Reports $13.8M Revenue and $23.5M Net Loss for Q2 2025
Constellation Acquisition Corp IConstellation Acquisition Corp I Reports Net Loss of $220,858 for Quarter Ending June 30, 2025
Generation Bio Co.Generation Bio Reports 81% Decline in Collaboration Revenue and $20.9 Million Net Loss in Q2 2025
CalciMedica, Inc.CalciMedica Reports Increased Net Loss of $10.998 Million for First Half of 2025
Rocket One Inc.Hoth Therapeutics Reports $2.2 Million Net Loss in Q2 2025, Increases R&D Spending
MV Oil TrustMV Oil Trust Reports Significant Decline in Financial Performance for Q2 2025
STANDARD PREMIUM FINANCE HOLDINGS, INC.Standard Premium Finance Reports Q2 2025 Results with Revenue Decline and Net Income Increase
Lyell Immunopharma, Inc.Lyell Immunopharma Reports $42.7 Million Net Loss in Q2 2025, Revenue Declines
Lionheart HoldingsLionheart Holdings Reports $2.25 Million Net Income for Quarter Ending June 30, 2025
MIDDLEFIELD BANC CORPMiddlefield Banc Corp. Reports 47.9% Increase in Q2 Net Income to $6.2 Million
CHAIN BRIDGE BANCORP INCChain Bridge Bancorp Reports $10.2 Million Net Income for First Half of 2025
Autolus Therapeutics plcAutolus Therapeutics Reports $20.9M Product Revenue in Q2 2025, Net Loss of $47.9M
Rigetti Computing, Inc.Rigetti Computing Reports 42% Revenue Decline in Q2 2025, Net Loss of $39.7 Million
Kyverna Therapeutics, Inc.Kyverna Therapeutics Reports $42.1 Million Net Loss in Q2 2025, Increases Investment in Clinical Trials
ADC Therapeutics SAADC Therapeutics Reports 8.2% Revenue Growth but Increases Net Loss in Q2 2025
Prairie Operating Co.Prairie Operating Co. Reports $68.1 Million Revenue and $35.7 Million Net Income for Quarter Ending June 30, 2025
TriSalus Life Sciences, Inc.TriSalus Life Sciences Reports 52.3% Revenue Growth but Incurred $9M Net Loss in Q2 2025